These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 4578848

  • 21. Relationship between serum concentration and daily dose of dantrolene in cerebral palsy patients.
    Inotsume N, Higashi A, Matsukane I, Chikazawa S, Nakano M, Matsuda I.
    Pediatr Pharmacol (New York); 1986; 5(4):253-9. PubMed ID: 3737270
    [Abstract] [Full Text] [Related]

  • 22. Effect of dantrolene sodium on the incidence of seizures in children with spasticity.
    Nogen AG.
    Childs Brain; 1979; 5(4):420-5. PubMed ID: 378580
    [Abstract] [Full Text] [Related]

  • 23. Pharmacotherapy of spasticity: oral medications and intrathecal baclofen.
    Krach LE.
    J Child Neurol; 2001 Jan; 16(1):31-6. PubMed ID: 11225954
    [Abstract] [Full Text] [Related]

  • 24. The effect of Dantrium on spasticity in multiple sclerosis.
    Ladd H, Oist C, Jonsson B.
    Acta Neurol Scand; 1974 Jan; 50(4):397-408. PubMed ID: 4277694
    [No Abstract] [Full Text] [Related]

  • 25. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
    Pinder RM, Brogden RN, Speight TM, Avery GS.
    Drugs; 1977 Jan; 13(1):3-23. PubMed ID: 318989
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Effects of dantrolene sodium on pyramidal hypertonia. Clinico-electrophysiological study].
    Caruso G, Fels A, Santoro L, Perretti A.
    Acta Neurol (Napoli); 1977 Jan; 32(6):872-83. PubMed ID: 343514
    [No Abstract] [Full Text] [Related]

  • 28. Clinical assessment and pharmacologic therapy of spasticity.
    Pedersen E.
    Arch Phys Med Rehabil; 1974 Aug; 55(8):344-54. PubMed ID: 4277407
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
    Tolosa ES, Soll RW, Loewenson RB.
    JAMA; 1975 Sep 08; 233(10):1046. PubMed ID: 1099254
    [No Abstract] [Full Text] [Related]

  • 31. Medical treatment for spasticity in children with cerebral palsy.
    Nogen AG.
    Childs Brain; 1976 Sep 08; 2(5):304-8. PubMed ID: 798660
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Pathogenetic therapy of spasticity].
    Kasatkin DS.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008 Sep 08; 108(3):80-5. PubMed ID: 18697257
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease.
    Weiser R, Terenty T, Hudgson P, Weightman D.
    Practitioner; 1978 Jul 08; 221(1321):123-7. PubMed ID: 366589
    [No Abstract] [Full Text] [Related]

  • 38. [Management of spasticity in children with cerebral palsy].
    Matthews DJ, Balaban B.
    Acta Orthop Traumatol Turc; 2009 Jul 08; 43(2):81-6. PubMed ID: 19448346
    [Abstract] [Full Text] [Related]

  • 39. Letter: Dantrolene ineffective in myotonic dystrophy.
    Lancet; 1975 May 03; 1(7914):1034-2. PubMed ID: 48704
    [No Abstract] [Full Text] [Related]

  • 40. Oral baclofen increases maximal voluntary neuromuscular activation of ankle plantar flexors in children with spasticity due to cerebral palsy.
    van Doornik J, Kukke S, McGill K, Rose J, Sherman-Levine S, Sanger TD.
    J Child Neurol; 2008 Jun 03; 23(6):635-9. PubMed ID: 18281622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.